228 related articles for article (PubMed ID: 9273301)
21. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
Janssen B; Gaebel W
MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
[TBL] [Abstract][Full Text] [Related]
22. Relationship between residual symptomatology and auditory evoked potentials in schizophrenic outpatients.
Hegerl U; Gaebel W; Ulrich G
Pharmacopsychiatry; 1988 Nov; 21(6):329-30. PubMed ID: 2907638
[No Abstract] [Full Text] [Related]
23. [Neuroendocrinology and schizophrenia research].
Müller-Spahn F
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
[No Abstract] [Full Text] [Related]
24. Towards systemic theories in biological psychiatry.
Bender W; Albus M; Möller HJ; Tretter F
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S4-9. PubMed ID: 16508889
[TBL] [Abstract][Full Text] [Related]
25. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
26. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
27. Schizophrenia: into the next millennium.
Jones B
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
[TBL] [Abstract][Full Text] [Related]
28. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
29. [Transmitter dysfunction in patients with schizophrenia. Significance for cognitive functioning and treatment].
Glenthøj BY; Mackeprang T; Bille AE; Hemmingsen RP
Ugeskr Laeger; 1999 Mar; 161(10):1391-8. PubMed ID: 10085745
[TBL] [Abstract][Full Text] [Related]
30. [Possible relevance of alterations at the cellular, neuronal connectivity and brain structure levels to the pathophysiology of schizophrenia].
Berger E; Shiloh R; Weizman A; Munitz H
Harefuah; 2001 Jul; 140(7):648-52. PubMed ID: 11481973
[No Abstract] [Full Text] [Related]
31. Has there been progress in schizophrenia research and treatment for all peoples during 2008? Existing disparities in mental healthcare and research?
DeLisi LE; Fleischhacker W
Curr Opin Psychiatry; 2009 Mar; 22(2):129-30. PubMed ID: 19553865
[No Abstract] [Full Text] [Related]
32. The Psychiatric Symptom Assessment Scale (PSAS).
Bigelow LB; Berthot BD
Psychopharmacol Bull; 1989; 25(2):168-73. PubMed ID: 2574891
[No Abstract] [Full Text] [Related]
33. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostic principles for differential therapy of psychoses].
Hell D; Bridler R
Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
36. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
37. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
38. [Instruments of depression assessment in schizophrenia].
Ramírez N; Sarro S; Arranz B; Sánchez J; González J; San L
Actas Esp Psiquiatr; 2001; 29(4):259-68. PubMed ID: 11470061
[TBL] [Abstract][Full Text] [Related]
39. Serotonin receptor responsivity in schizophrenia.
Kahn RS; Davidson M
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140
[No Abstract] [Full Text] [Related]
40. [Medication-related attitudes of chronic schizophrenic patients. A follow-up study after psycho-educational intervention].
Hornung WP; Schonauer K; Feldmann R; Mönking HS
Psychiatr Prax; 1998 Jan; 25(1):25-8. PubMed ID: 9530765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
